Re Agreement

RNS Number:6469N
Celsis International PLC
17 July 2003

                            Celsis International plc

           Sanofi-Synthelabo agreement with Celsis Laboratory Group

Celsis Laboratory Group, part of the Celsis International plc group of
companies, a leading US supplier of cGMP analytical services for the
pharmaceutical industry, has entered into a master services agreement with
Sanofi-Synthelabo.  Celsis will provide various chemistry and microbiology
analytical testing services to Sanofi-Synthelabo's US and Puerto Rican
subsidiaries.

Sanofi-Synthelabo principle area of business is ethical pharmaceuticals and the
company ranks among the world's top twenty pharmaceutical companies.  Their core
therapeutic areas are cardiovascular disease and thrombosis, diseases of the
central nervous system, cancer and internal medicine.

Jay LeCoque, Chief Executive Officer, Celsis stated:

"Establishing this agreement with Sanofi-Synthelabo, a major pharmaceutical
company, is a great success for Celsis and highlights our Laboratory Group's new
business development strategy is having an impact.  We will continue to expand
our customer base by providing high quality services with superior customer
service to maintain our leading position in the cGMP testing arena."

                                                                    17 July 2003


Enquiries:
Celsis Laboratory Group                               Tel: [phone]
Rich Segiel, Director, Business Development


Celsis International plc                              Tel: [phone]
Jay LeCoque, Chief Executive Officer
Jenny Parsons, Corporate Communications


College Hill                                          Tel: [phone]
Nicholas Nelson



Notes to editors

Celsis Laboratory Group

Celsis Laboratory Group, part of the Celsis International plc group of
companies, is a leading US supplier of cGMP analytical services.  Celsis
Laboratory Group provides a cost effective and broad range of quality control
testing services to its customers.  Many Fortune 500 companies in the
pharmaceutical, chemical and cosmetic industries have come to rely upon the
Celsis Laboratory Group to fulfil their testing needs.

Celsis Laboratory Group's services include comprehensive testing in the areas of
analytical chemistry, microbiology, stability storage & testing and quality
assurance.  With facilities in Edison, New Jersey, (USA) and St Louis, Missouri,
(USA) Celsis Laboratory Group has a uniform commitment to quality and customer
service across its operations.  Both laboratories are FDA registered and
function under current Good Manufacturing Practices (cGMP) and applicable Good
Laboratory Practices (GLP) and have been successfully audited by regulatory
agencies (FDA, EPA, DEA) and 9 out of the top 10 worldwide pharmaceutical
companies.

For more information on Celsis International plc or Celsis Laboratory Group go
to www.celsis.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

AGRNKAKPFBKDBOD